Marketocracy Masters Capital Management

Marketocracy runs a persistent virtual trading platform where amateur investors build model portfolios tracked against real market conditions. The firm applies quantitative screening to surface the top-ranked track records — filtering for consistency over style, sector, and market cycles — and then aggregates the highest-conviction common holdings from those top performers into a composite managed portfolio.

It operates as a regulated mutual fund under the Investment Company Act of 1940. This means daily liquidity, disclosed holdings, and standard diversification rules — a deliberate choice that gave retail investors access to the model without the accredited-investor or lockup constraints typical of a hedge fund structure.

The firm earns management fees from the mutual fund vehicle it manages. The precise fee schedule is disclosed in the fund's prospectus. The model itself — the virtual trading platform — operates as a talent-sourcing pipeline rather than a direct revenue engine, with the economics realized through assets gathered into the regulated product.

Ken Kam spent his early career as an equity analyst covering biotech at Amgen and later co-founded Odyssey Capital, a healthcare-focused investment partnership. His analytical discipline from that sector — identifying underappreciated talent and performance signals in noisy data — directly influenced the quantitative filtering logic behind Marketocracy's talent-scouting model (public record).

The strategy operates through a publicly traded mutual fund and invests in publicly listed equities. There is no public record of the firm making direct private-company investments, taking board seats, or running a venture-style allocation program.